• Seeking Alpha

PharmAla Delivers MDMA to Merhavim Mental Health Centre Clinical Trial in Exchange for Full Data License

Seeking Alpha / 1 hour from now 1 Views

PharmAla delivers over 500 LaNeo MDMA capsules to Merhavim Psychiatric Hospital to be used in a clinical trial in exchange for IP rights to trial results
Read more
  • Source:
  • GlobeNewswire - News about Public Companies
Previous post
Blue Gold Adds Veteran Wall Street Financier & Fintech Innovator Jeremy Frommer to Advisory Board to Drive Tokenized Gold Strategy
Next post
LPL Financial and Financial Resources Group Welcome Coastal Wealth Management Group

Comments

Just Posted

  • Dorel Provides Update on Long-Term Debt

    3 hours from now

  • Dorel fait le point sur sa dette à long terme

    3 hours from now

  • Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons

    3 hours from now

  • Gray Media and Graham Media Group Raise More Than $1.1 Million Dollars for Texas Flooding Relief

    3 hours from now

  • Zealand Pharma conference call on August 14 at 2pm CET (8am ET) to present second quarter 2025 financial results

    3 hours from now

Tags

  • SA Transcripts
  • TOU:CA
  • Gold Mining Bull
  • TPZ
  • NG1:COM
  • CHK
  • TRMLF
  • fivn
  • CGIFF
  • CHE.UN:CA

Reviews

Categories

  • Seeking Alpha 1408

Categories

  • Seeking Alpha 1408

Pages

Tags

  • SA Transcripts
  • TOU:CA
  • Gold Mining Bull
  • TPZ
  • NG1:COM
  • CHK
  • TRMLF
  • fivn
  • CGIFF
  • CHE.UN:CA

Copyright News That Move � 2018. All Rights Reserved

  • Seeking Alpha
  • Trade Halts